Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04316715 · ClinicalTrials.gov registry record · NA
Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care
A NA study of Adherence, Medication, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT04316715: Completed NA study of Adherence, Medication, sponsored by University of Miami.
NCT04316715 is a NA study of Adherence, Medication that has completed, run by University of Miami. The registered enrollment target is 300 participants, below the 814-participant average among 13 other Adherence, Medication trials with a reported enrollment target (63% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04316715, a NA study of Adherence, Medication, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test how different types of interventions may affect how someone takes their pre-exposure prophylaxis (PrEP) medication.
Primary Outcome
Medication adherence as reported by Tenofovir diphosphate (TFV-DP) concentrations measured using dried blood spot (DBS) testing.
Conditions Studied
Interventions
- BEHAVIORAL Lifesteps for PrEP
- BEHAVIORAL Daily text message reminders
Study Locations (2)
Florida
- University of Miami - Miami
Massachusetts
- Fenway Health - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-09-03 |
| Est. Completion | 2025-08-01 |
| Phase | NA |
What the finished NCT04316715 record still lists
NCT04316715 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 814-participant average among 13 other Adherence, Medication trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Adherence, Medication appearing as the primary indexed condition, and to 2 interventions - of which Lifesteps for PrEP is the first listed.
NCT04316715 reports a single indexed study location in Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04316715 about?
NCT04316715 is a clinical study titled "Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care". The purpose of this study is to test how different types of interventions may affect how someone takes their pre-exposure prophylaxis (PrEP) medication.
What is the current status of trial NCT04316715?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2020-09-03. Estimated completion is 2025-08-01.
What conditions does trial NCT04316715 study?
This clinical trial studies the following conditions: Adherence, Medication.
What interventions are being tested in trial NCT04316715?
The interventions under investigation include: Lifesteps for PrEP (BEHAVIORAL), Daily text message reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT04316715?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04316715 being conducted?
This trial has 2 study locations across Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adherence, Medication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04316715's enrollment target sits among peer trials
300 3rd of 13 higher than 11 of 13 other Adherence, Medication trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adherence, Medication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
RECRUITING · NA
-
Mobile Health Program for Rural Hypertension
RECRUITING · NA
-
BMT4me: Post-HSCT Medication Adherence mHealth App
RECRUITING · NA
-
Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications
COMPLETED · NA
-
Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users
COMPLETED · NA
-
The Impact of Patch Rx Technologies on Adherence to Vitamin and Trikafta Therapies in Patients With Cystic Fibrosis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI